PMID:8434007: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
Edited by wikibot
imported>Wikientrybot
change PMID template to TableEdit version
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{RightTOC}}
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.132176.P522399c9959fd-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="P522399c9959fd"  class=" tableEdit PMID_info_table" 


<span style = 'font-size: large'> '''Swain, AL, Jaskólski, M, Housset, D, Rao, JK and Wlodawer, A'''  (1993) Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy.''Proc. Natl. Acad. Sci. U.S.A.'' '''90''':1474-8</span>
|-
!align=left  |Citation
||
'''Swain, AL, Jaskólski, M, Housset, D, Rao, JK and Wlodawer, A'''  (1993) Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. ''Proc. Natl. Acad. Sci. U.S.A.'' '''90''':1474-8
|-
!align=left  |Abstract
||
The crystal structure of Escherichia coli asparaginase II (EC 3.5.1.1), a drug (Elspar) used for the treatment of acute lymphoblastic leukemia, has been determined at 2.3 A resolution by using data from a single heavy atom derivative in combination with molecular replacement. The atomic model was refined to an R factor of 0.143. This enzyme, active as a homotetramer with 222 symmetry, belongs to the class of alpha/beta proteins. Each subunit has two domains with unique topological features. On the basis of present structural evidence consistent with previous biochemical studies, we propose locations for the active sites between the N- and C-terminal domains belonging to different subunits and postulate a catalytic role for Thr-89.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8434007 PubMed] [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC45896 PMC45896]


{|{{Prettytable}} align = 'center' width= '70%'
|-
|-
|{{TableHeadingColor}} |'''Abstract''' || The crystal structure of Escherichia coli asparaginase II (EC 3.5.1.1), a drug (Elspar) used for the treatment of acute lymphoblastic leukemia, has been determined at 2.3 A resolution by using data from a single heavy atom derivative in combination with molecular replacement. The atomic model was refined to an R factor of 0.143. This enzyme, active as a homotetramer with 222 symmetry, belongs to the class of alpha/beta proteins. Each subunit has two domains with unique topological features. On the basis of present structural evidence consistent with previous biochemical studies, we propose locations for the active sites between the N- and C-terminal domains belonging to different subunits and postulate a catalytic role for Thr-89.
!align=left  |Keywords
</noinclude>
||
|-
Amino Acid Sequence; Asparaginase/chemistry; Asparaginase/therapeutic use; Binding Sites; Escherichia coli/enzymology; Humans; Macromolecular Substances; Models, Molecular; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Protein Conformation; Protein Structure, Secondary; Threonine; X-Ray Diffraction
|{{TableHeadingColor}} nowrap |'''Links''' ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8434007 PubMed]
 
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.132176.P522399c9959fd&page=132176&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
|}
 
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.132176.P522399c9959fd-->
==Significance {{HelpIcon|Help:Literature}} ==
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
{{LitSignificance}}
Line 18: Line 38:


==Annotations {{HelpIcon|Help:Literature}}==
==Annotations {{HelpIcon|Help:Literature}}==
<!--box uid=63ce1649aab8b3180235b0af7618f667.0.F47ab7c7615287-->
<annotationlinks/>
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|class = 'sortable' {{Prettytable}} id='240000'
|- {{table heading style}}
!Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status
|-class='sortbottom'
|[{{SERVER}}{{SCRIPTPATH}}/index.php?title=Special:TableEdit&id=63ce1649aab8b3180235b0af7618f667.0.F47ab7c7615287&page=0&pagename={{FULLPAGENAMEE}} edit table] || || || || || || || ||
|}
<!--box uid=63ce1649aab8b3180235b0af7618f667.0.F47ab7c7615287-->


==EcoliWiki Links {{HelpIcon|Help:Literature}} ==
==EcoliWiki Links {{HelpIcon|Help:Literature}} ==

Latest revision as of 04:54, 15 September 2013

Citation

Swain, AL, Jaskólski, M, Housset, D, Rao, JK and Wlodawer, A (1993) Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 90:1474-8

Abstract

The crystal structure of Escherichia coli asparaginase II (EC 3.5.1.1), a drug (Elspar) used for the treatment of acute lymphoblastic leukemia, has been determined at 2.3 A resolution by using data from a single heavy atom derivative in combination with molecular replacement. The atomic model was refined to an R factor of 0.143. This enzyme, active as a homotetramer with 222 symmetry, belongs to the class of alpha/beta proteins. Each subunit has two domains with unique topological features. On the basis of present structural evidence consistent with previous biochemical studies, we propose locations for the active sites between the N- and C-terminal domains belonging to different subunits and postulate a catalytic role for Thr-89.

Links

PubMed PMC45896

Keywords

Amino Acid Sequence; Asparaginase/chemistry; Asparaginase/therapeutic use; Binding Sites; Escherichia coli/enzymology; Humans; Macromolecular Substances; Models, Molecular; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Protein Conformation; Protein Structure, Secondary; Threonine; X-Ray Diffraction

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

<annotationlinks/>

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

References

See Help:References for how to manage references in EcoliWiki.